One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Views and reviews: fertility preservation from different perspectives
Laura Rienzi, Prof
doi : 10.1016/j.fertnstert.2024.01.010
Volume 121, Issue 4, April 2024, Pages 551-552
Fertility preservation counseling: old indications, novel perspectives
Estelle Hagege, M.D., a Sean Sokteang, M.D., b Jean Marc Ayoubi, M.D., a and Dominique de Ziegler, M.D.
doi : 10.1016/j.fertnstert.2024.01.004
Volume 121, Issue 4, April 2024, Pages 553-554
Oocyte vitrification for fertility preservation is an evolving practice requiring a new mindset: societal, technical, clinical, and basic science-driven evolutions
Danilo Cimadomo, Ph.D., a Ana Cobo, Ph.D., b Daniela Galliano, M.D., Ph.D., c Giulia Fiorentino, Ph.D., d Anabella Marconetto, M.Sc., e Maurizio Zuccotti, Prof., d and Laura Rienzi, Prof.
doi : 10.1016/j.fertnstert.2024.01.003
Volume 121, Issue 4, April 2024, Pages 555-561
Intracytoplasmic sperm injection revisited: ideal intervention or purveyor of disease?
Peter N. Schlegel, M.D.
doi : 10.1016/j.fertnstert.2024.02.026
Volume 121, Issue 4, April 2024, Page 562
Intracytoplasmic sperm injection is still the best management of male factor infertility
Philip Xie, B.S., a Stephanie Cheung, M.S., a Olena Kocur, B.A., a Lily Ng, B.S., a Angela De Jesus, B.S., a Zev Rosenwaks, M.D., a Gianpiero D. Palermo, M.D., Ph.D., a Robert John Aitken, Ph.D., Sc.D., b,c and Peter N. Schlegel, M.D. d
doi : 10.1016/j.fertnstert.2024.02.025
Volume 121, Issue 4, April 2024, Pages 563-575
To sleep perchance to dream…of pregnancy
Sarah C. Cromack, M.D. Jessica Walter, M.D. Eve C. Feinberg, M.D.
doi : 10.1016/j.fertnstert.2023.12.010
Volume 121, Issue 4, April 2024, Pages 576-577
The use of fertility treatments among reproductive-aged women after cancer
Lauren M. Kipling, Ph.D., a Lisa M. Shandley, M.D., M.Sc., b Ann C. Mertens, Ph.D., c Jessica B. Spencer, M.D., M.Sc., b and Penelope P. Howards, Ph.D.
doi : 10.1016/j.fertnstert.2023.12.012
Volume 121, Issue 4, April 2024, Pages 578-588
Tobacco or marijuana use and infertility: a committee opinion
Practice Committee of the American Society for Reproductive Medicine
doi : 10.1016/j.fertnstert.2023.12.029
Volume 121, Issue 4, April 2024, Pages 589-603
Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion
Ethics Committee of the American Society for Reproductive Medicine
doi : 10.1016/j.fertnstert.2023.12.030
Volume 121, Issue 4, April 2024, Pages 604-612
Why would menses be related to the day of the week or to the lunar cycle?
doi : 10.1016/j.fertnstert.2024.02.036
Volume 121, Issue 4, April 2024, Page 613
Polycystic ovary syndrome and antimüllerian hormone—can there be too much of a good thing?
Jessica R. Zolton, D.O.
doi : 10.1016/j.fertnstert.2024.01.038
Volume 121, Issue 4, April 2024, Page 614
Impact of oxygen tension during in vitro maturation: a sibling-oocyte prospective double-blinded study
Yasmine Boumerdassi, M.D., a,b Julie Labrosse, M.D., c Fatma Hammami, M.D., a Mehdi Dahoun, M.D., a Jean Bouyer, Ph.D., d Louis O’Neill, Pharm.D., a Solmaz Sarandi, M.D., a Maeliss Peigne, M.D., Ph.D., c Isabelle Cedrin, M.D., c Michael Grynberg, M.D., Ph.D., c,e,f,g and Christophe Sifer, Pharm.D., M.Sc.
doi : 10.1016/j.fertnstert.2023.12.014
Volume 121, Issue 4, April 2024, Pages 615-621
International gestational surrogacy in the United States, 2014–2020
Alexandra Herweck, M.D., M.P.H., a Carol DeSantis, M.P.H., a Lisa M. Shandley, M.D., b Jennifer F. Kawwass, M.D., b and Heather S. Hipp, M.D
doi : 10.1016/j.fertnstert.2023.12.039
Volume 121, Issue 4, April 2024, Pages 622-630
Sphingosine-1-phosphate receptor 3 is a non-hormonal target to counteract endometriosis-associated fibrosis
Caterina Bernacchioni, Ph.D., a Margherita Rossi, B.Sc., a Valentina Vannuzzi, Ph.D.,b Matteo Prisinzano, B.Sc., a Isabelle Seidita, B.Sc., a Maryam Raeispour, B.Sc., a Angela Muccilli, M.D., c Francesca Castiglione, M.D., c Paola Bruni, Ph.D., a Felice Petraglia, M.D., a,b and Chiara Donati, Ph.D. a
doi : 10.1016/j.fertnstert.2023.12.007
Volume 121, Issue 4, April 2024, Pages 631-641
Association between serum 25-hydroxyvitamin D and antimüllerian hormone levels in a cohort of African-American women
Anita Subramanian, Ph.D., a Quaker E. Harmon, M.D., Ph.D., a Lia A. Bernardi, M.D., b Mercedes R. Carnethon, Ph.D., c Erica E. Marsh, M.D., d Donna D. Baird, Ph.D., a and Anne Marie Z. Jukic, Ph.D.
doi : 10.1016/j.fertnstert.2023.12.023
Volume 121, Issue 4, April 2024, Pages 642-650
The menstrual cycle is influenced by weekly and lunar rhythms
Rene Ecochard, M.D., Ph.D., a,b Rene Leiva, M.D., c,d Thomas P. Bouchard, M.D., e Agathe Van Lamsweerde, M.Sc., f Jack T. Pearson, Ph.D., f Joseph B. Stanford, M.D., M.S.P.H., g and Claude Gronfier, Ph.D. h
doi : 10.1016/j.fertnstert.2023.12.009
Volume 121, Issue 4, April 2024, Pages 651-659
Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin
Allison S. Komorowski, M.D., a Lydia Hughes, M.D., a Prottusha Sarkar, B.A., b David A. Aaby, M.S., c Ajay Kumar, Ph.D., d Bhanu Kalra, Ph.D., d Richard S. Legro, M.D., e and Christina E. Boots, M.D.
doi : 10.1016/j.fertnstert.2023.12.031
Volume 121, Issue 4, April 2024, Pages 660-668
Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study
Tsai-Der Chuang, Ph.D., a,b Nhu Ton, B.S., b Shawn Rysling, B.S., b Derek Quintanilla, B.S., b Drake Boos, B.S., b and Omid Khorram, M.D., Ph.D
doi : 10.1016/j.fertnstert.2023.12.006
Volume 121, Issue 4, April 2024, Pages 669-678
Laparoscopic Davydov vs. laparoscopic Vecchietti neovaginoplasty in women with Mayer-Rokitansky-Küster-Hauser syndrome; a systematic review and meta-analysis
Lisanne Martens, M.D., a Linde Tannenbaum, M.D., a Sander M. J. Van Kuijk, Ph.D., b Kim J. B. Notten, M.D., Ph.D., a and Kirsten B. Kluivers, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2023.12.015
Volume 121, Issue 4, April 2024, Pages 679-692
Cost-effectiveness analyses of preimplantation genetic testing
doi : 10.1016/j.fertnstert.2023.12.022
Volume 121, Issue 4, April 2024, Pages 693-702
vNOTES retroperitoneal transient uterine artery occlusion: a new approach to control bleeding during a high-risk evacuation of products of conception
Jan Baekelandt, M.D., Ph.D., a,b Jazz Storms, M.D., a Jan Bosteels, M.D., Ph.D., a,b and Andrea Stuart, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2024.01.012
Volume 121, Issue 4, April 2024, Pages 703-705
Response to Individualized vs. conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
Salvatore Longobardi, M.D., Ph.D.a Thomas M. D’Hooghe, M.D., Ph.D
doi : 10.1016/j.fertnstert.2023.12.024
Volume 121, Issue 4, April 2024, Page 706
Reply of the Authors: Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
Scott M. Nelson, M.R.C.O.G., Ph.D.a Bart C.J.M. Fauser, M.D., Ph.D.b Juan Antonio Garc?a-Velasco, M.D., Ph.D. c Bjarke M. Klein, Ph.D.d Joan-Carles Arce, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2024.01.019
Volume 121, Issue 4, April 2024, Page 707
Retraction notice to "The Impact of Laparoscopic Cystectomy on Ovarian Reserve in Patients with Unilateral and Bilateral Endometriomas"
doi : 10.1016/j.fertnstert.2024.02.028
Volume 121, Issue 4, April 2024, Page 712
Expression of concern: “Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia�
doi : 10.1016/j.fertnstert.2024.02.034
Volume 121, Issue 4, April 2024, Page 713
Expression of concern: “Extended resectoscopic versus sequential cold knife-resectoscopic excision of the unclassified complete uterocervicovaginal septum: a randomized trial�
doi : 10.1016/j.fertnstert.2024.02.035
Volume 121, Issue 4, April 2024, Page 714
